About
Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. The firm identifies and invests in emerging companies that are developing transformative medicines and technologies with the potential to enhance Pfizeržs pipeline and shape the future of the industry. With a $900M Capital commitment for investment, Pfizer Ventures backs private companies at all stages of development, focusing primarily on early stage opportunities. Investments are focused on potentially transformative therapeutics, emphasizing core therapeutic areas such as Inflammation & Immunology, Internal Medicine, Oncology, AntiInfectives, and Vaccines. The firm also considers platform technologies, diagnostics, drug delivery, pharmaceutical services, and other technologies that have the potential to transform drug discovery and development. Pfizer Ventures is an active investor offering both Capital and strategic guidance.